Researchers call for better linkage of health data during discussions with members of the Bundestag

NFDI4Health and experts from politics, science, and healthcare met in Berlin on 13 March 2024 to discuss the topic of record linkage – the linkage of health data from diverse sources for an individual. The participants consider the meeting a success and are planning further steps: ultimately, the entire population could benefit.

As part of the background research for this article, I delved deeper into the topics of record linkage and the role of NFDI4Health. Here’s what I found:

Record linkage is a technique used to join up data records from several disparate sources that refer to the same entity. In healthcare, this process involves connecting different databases containing health information about an individual.

The advantage of effective record linkage includes a more comprehensive picture of patient health status, which could improve disease diagnosis and outcomes and help policymakers understand population health trends better.

NFDI4Health is part of Germany’s National Research Data Infrastructure (NFDI). It seeks to optimally organize, # standardize and provide access to research data from healthcare despite diverse structures in source systems.

FAQ:

Q1: What is record linkage in healthcare?
A1: Record linkage in healthcare involves combining different databases containing health information about an individual. By doing so, doctors can achieve a more complete overview of patient conditions and history.

Q2: How does the general population benefit from effective record linkages?
A2: Effective record linkages allow for faster diagnoses by providing doctors with full pictures of patient conditions immediately. This helps reduce unnecessary tests or unfortunate misdiagnoses while facilitating targeted treatment plans. Moreover, it can also lead to timely public health interventions when patterns are recognized at a population level.

Q3: What exactly does NFDI4Health do?
A3: As part of Germany’s National Research Data Infrastructure (NFDI), NFDI4Health aims to manage healthcare research data optimally – standardizing it despite diverse structures in source systems -and making it accessible for further use and analysis.

Q4: Who were involved in this meeting discussed mentioned on 13 March 2024?
A4: The meeting was attended by representatives from politics, science, as well as experts from NFDI4Health aimed at discussing the importance and execution of record linkage in healthcare.

Q5: What are the expected next steps after this meeting?
A5: The details of further steps were not provided in the press release; however, it’s implied that there will be ongoing discussions and action towards improving record linkage, providing better health care services for German citizens.

Originamitteilung:

NFDI4Health and experts from politics, science, and healthcare met in Berlin on 13 March 2024 to discuss the topic of record linkage – the linkage of health data from diverse sources for an individual. The participants consider the meeting a success and are planning further steps: ultimately, the entire population could benefit.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Gesundheits- und Umweltexperte an der Hochschule Coburg werden

Gesundheit oder Umwelt: Was darfs sein? Wenn Studierende der Hochschule Coburg nach drei Semestern die Grundlagen der Bioanalytik erlernt haben, können sie sich spezialisieren. Auch im Masterstudium dürfen sie ihren Fokus auf Bioinformatik, Ökotoxikologie oder Humanbiologie setzen. Dadurch wird die Lehre flexibler und zeiteffizient. Zwei neuberufene Professoren geben Einblicke in das Studium und ihre Arbeit als Professoren.

Read More

Glioblastom: Humanin blockieren – Chemotherapie wirksam machen

Strahlen- und/oder Chemotherapie nach der Operation – das sind die Behandlungsoptionen bei einem der gefährlichsten Gehirntumore überhaupt, dem Glioblastom. Doch bis heute sind diese Tumoren unheilbar, mit einer mittleren Überlebensdauer von 16 Monaten nach Diagnosestellung. Nun hat ein Team internationaler Forschender unter Federführung von Prof. Dr. Rainer Glaß vom LMU Klinikum München einen Mechanismus entdeckt, der die Krebszellen gegen gängige Chemotherapeutika unempfindlich macht. Die Ergebnisse wurden jetzt in der Fachzeitschrift „Cell Reports Medicine“ veröffentlicht.

Read More